CSW to partner with Visbion

AuntMinnieEurope.com staff writers

May 22, 2007

Oxford, U.K.-based CSW Group has signed an OEM agreement to incorporate its Case Notes product with Visbion's DICOM imaging technology for electronic health records.

Visbion of Surrey, U.K., specializes in medical image management and display technologies for the acquisition, storage, archive, and display of medical images.

The new configuration will allow CSW's Case Notes to handle medical images using the DICOM 3.0 standard.

By AuntMinnie.com staff writers
May 23, 2007

Copyright © 2007 AuntMinnie.com

Low-quality axial T2-weighted MRI scans with gradient-weighted class activation mapping. The low-quality MRI scans (top row) show blurred structures and artifacts making zonal and capsule boundaries indistinguishable. On the same scans with gradient-weighted class activation map overlays (bottom row), red indicates regions that were most heavily weighted by the deep learning model toward the low-quality prediction.

AI framework could improve MRI quality control in prostate cancer

August 19, 2026

Nanox AI signs UK distribution deal for HealthOST bone health software

August 18, 2026

Pexels Cottonbro 5867701 (1)

Review highlights opportunities and risks of AI in pediatric imaging

August 17, 2026

Shutterstock 1918864388

AI performs well in breast screening, but density complicates the picture

August 13, 2026

AI framework could improve MRI quality control in prostate cancer

By Amerigo Allegretto

The framework uses a DL model trained on low- and high-quality MR images and helped improve radiologist accuracy.

August 19, 2026

Low-quality axial T2-weighted MRI scans with gradient-weighted class activation mapping. The low-quality MRI scans (top row) show blurred structures and artifacts making zonal and capsule boundaries indistinguishable. On the same scans with gradient-weighted class activation map overlays (bottom row), red indicates regions that were most heavily weighted by the deep learning model toward the low-quality prediction.

Nanox AI signs UK distribution deal for HealthOST bone health software

By AuntMinnieEurope.com staff writers

HealthOST analyzes routine CT scans for spine assessment.

August 18, 2026

Review highlights opportunities and risks of AI in pediatric imaging

By Claudia Tschabuschnig

Adult-trained AI tools may underperform in children, requiring pediatric-specific datasets, age-stratified validation, and stronger clinical oversight for safe deployment, researchers say.

August 17, 2026

Pexels Cottonbro 5867701 (1)

AI performs well in breast screening, but density complicates the picture

By Claudia Tschabuschnig

While AI can support breast cancer risk assessment, its performance declined as breast density increased, while variations related to equipment vendor and measurement level may complicate personalized screening.

August 13, 2026

Shutterstock 1918864388

Azra AI, Blackford form imaging, care navigation partnership

By AuntMinnie.com staff writers

The companies aim to ensure patients identified through imaging are promptly reached and managed through the appropriate care pathway.

August 5, 2026

Median Technologies signs Canon Medical partnership for eyonis LCS

By AuntMinnie.com staff writers

Canon's subsidiary Olea Medical will leverage its CT imaging platform to support distribution of Median's software.

July 30, 2026

Business Handshake Intelligence 400 (1)

EU AI Act brings radiology AI oversight into daily practice

By Claudia Tschabuschnig

A new opinion paper calls on European imaging departments to strengthen AI auditing and monitoring in patient care.

July 21, 2026

The European Parliament in Brussels approved the EU AI Act in 2024, establishing a risk-based regulatory framework for artificial intelligence, including high-risk medical AI systems.

Radiologists can identify three out of four AI-generated images

By Amerigo Allegretto

Radiologists found it particularly difficult to distinguish between real and AI-generated CT and MR images.

July 17, 2026

Top eight incorrectly classified synthetic images (Most convincing fake images). Images A, B, C, D, E, F, G and H were the most infrequently correctly classified images at 24%, 43%, 59%, 64%, 69%, 71%, 71% and 73% respectively. All images are AI-generated. Images A, B and C are head CTs. Images D and E are chest CTs. Image F is a cardiac CT. Image G is a musculoskeletal MRI. Image H is a head MRI. Images are republished under a Creative Commons license (CC BY 4.0).

Incorrect AI suggestions influence reader performance on mammography

By Amerigo Allegretto

The biggest impact on reader performance stemmed from false-negative AI suggestions.

July 14, 2026

A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.

The cost of AI, and finding its breakeven point

By Claudia Tschabuschnig

Who pays, what, where, and when: speakers at the Royal College of Radiologists' Global AI Conference dug into what AI actually costs and when, if ever, it pays for itself.

July 9, 2026

Who's paying, and for what, is the question that actually decides whether AI in healthcare gets funded.

AI aims to decode targeted radiotherapy response

By Claudia Tschabuschnig

Same administered activity, different results. Speakers at the Royal College of Radiologists’ 2nd Annual Global AI Conference argued AI could help move targeted radionuclide therapy beyond a one-size-fits-all approach toward more precise, personalized treatment.

July 8, 2026

Experts at the Royal College of Radiologists’ 2nd Annual Global AI Conference discussed how AI could help move cancer care toward more personalized treatment, from targeted radionuclide therapy dosing to drug discovery.

RCR: Agentic AI is off the leash, and already a workhorse for health systems

By Claudia Tschabuschnig

The technical crowd took the stage at the 2nd Annual Global AI Conference in London last week, to show radiologists where agentic AI is running, how it operates across a spread of autonomy, and why only the highest tiers demand serious governance.

July 7, 2026

Dr. Rowland Illing, chief medical officer at Amazon Web Services (AWS) and a former interventional radiologist.

Page 1 of 418